Androgenetic Alopecia (AGA) is a progressive hair loss type affecting up to 80% of men and 50% of women. COMPLIFE performed a new study to test the effectiveness of a client’s product on this disease and published it on the “Journal of Cosmetology & Trichology.” Their Methods include: phototrichogram(Anagen, telogen and hair density were estimated in a target area and automatically calculated by TrichoScan® software), global photography assessment , and self assessment questionnaire.
Read the complete study on their website and contact them for further infos.
👉 Find out more about CompLife expertise on the 🥼 clinical testing platform : here
Kristel Adriaenssens Milet 1 April 2025 Social intelligence company Dynvibe, which specialises in behavioural marketing…
26 March 2025 The 35th IFSCC Congress will take place in Cannes from September 15…
This AI-powered skin diagnostic device uses bio-optical technology alongside AI algorithms to analyze the skin’s…